Plural Strategy Group has supported the management and shareholders of Random42 with Vendor CDD, culminating in a successful exit to Graphite Capital.
Random42 is the leading provider of scientifically accurate medical animations to global pharmaceutical companies. For more information, please contact Jim Easton, Phil Stone or Jamie Berridge.
